Chronic myeloid leukemia (CML) is a malignancy of the hematopoietic system characterized by Philadelphia chromosome (BCR–ABL1; refs. 14, 15). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.